FdaApplication
ANDA 204591
Identifiers
- fda_app_no: ANDA204591
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMS USA INC |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | 50MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
| SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | 50MG;500MG | TABLET, EXTENDED RELEASE;ORAL |
| SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE | 100MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
3 products